<SEC-DOCUMENT>9999999995-25-002673-index.html : 20250820
<SEC-HEADER>9999999995-25-002673.hdr.sgml : 20250820
<ACCEPTANCE-DATETIME>20250820001509
ACCESSION NUMBER:		9999999995-25-002673
CONFORMED SUBMISSION TYPE:	EFFECT
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250819
DATE AS OF CHANGE:		20250820
EFFECTIVENESS DATE:		20250819

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BridgeBio Oncology Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001869105
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		EFFECT
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-288222
		FILM NUMBER:		251233714

	BUSINESS ADDRESS:	
		STREET 1:		256 E. GRAND AVENUE, SUITE 104
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		857 702 0377

	MAIL ADDRESS:	
		STREET 1:		256 E. GRAND AVENUE, SUITE 104
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Helix Acquisition Corp. II
		DATE OF NAME CHANGE:	20210623
</SEC-HEADER>
<DOCUMENT>
<TYPE>EFFECT
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
</SEC-DOCUMENT>